ArticleJournal of gastrointestinal oncology2025
Impact of cancer-directed surgery for gastric cancer patients with lung metastasis: a prognosis analysis.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric cancer (GC) is acknowledged as a fatal malignant disease. The impact of cancer-directed surgery (CDS) on the prognosis of patients with lung metastatic gastric cancer (LMGC) was investigated in this study. Methods: The clinical data of LMGC patients after CDS were obtained from the Surveillance, Epidemiology, and End Results (SEER) database [2000-2020]. This study used the R software to perform propensity score matching (PSM). Then, the influence of different variables on overall survival (OS) was measured by Cox regression analysis and Kaplan-Meier curve analysis. Results: A total of 1,045 LMGC patients were included in the present study. Among these patients, 970 (92.82%) patients were assigned to the non-CDS group and 75 (7.18%) were assigned to the CDS group. After PSM, 165 (72.37%) patients in the non-CDS group and 63 (27.63%) patients in the CDS group were identified. The Kaplan-Meier analysis results revealed that the median OS was significantly longer in the CDS group (12 Conclusions: CDS may improve the prognosis of patients with LMGC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.